0 Commentaires
0 Parts
207 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Liquid Biopsy Market to Reach USD 29.2 Billion by 2036 as Precision Oncology and Non-Invasive Cancer Testing Drive Global GrowthThe global Liquid Biopsy Market is poised for substantial expansion as healthcare providers increasingly adopt minimally invasive cancer diagnostic technologies for early detection, treatment monitoring, and personalized medicine. According to the latest industry analysis, the global Liquid Biopsy Market is projected to grow from USD 7.3 billion in 2026 to USD 29.2 billion by 2036, registering...0 Commentaires 0 Parts 276 Vue 0 Aperçu
-
Non-Invasive Prenatal Testing Market: Future Trends and Growth ProspectsIn an increasingly competitive and evolving business landscape, making informed decisions backed by reliable data has become essential for sustained growth and strategic planning. Market intelligence serves as a critical tool for businesses to respond effectively to shifting consumer demands, technological advancements, and emerging market trends. At Polaris Market Research, we are committed to...0 Commentaires 0 Parts 104 Vue 0 Aperçu
-
Prenatal DNA Sequencing Market – Non-Invasive Testing Advances Maternal-Fetal CareThe prenatal DNA sequencing market is expanding as expectant parents and healthcare providers seek safer, more accurate methods for genetic screening during pregnancy. The market was valued at USD 1.3 billion in 2024 and is projected to grow from USD 1.5 billion in 2025 to USD 5 billion by 2035, at a CAGR of 13.1%. 1174 Prenatal DNA sequencing uses genetic analysis to assess certain fetal...0 Commentaires 0 Parts 132 Vue 0 Aperçu
-
Strategic Developments Accelerating the Non-Invasive Prenatal Testing (NIPT) MarketIn recent years, the Non-Invasive Prenatal Testing (NIPT) Market has witnessed a transformative evolution, with an expected market size of USD 1.82 billion in 2024 and reaching an estimated USD 5.5 billion by 2035. This significant growth, marked by a compound annual growth rate (CAGR) of 10.58%, indicates a profound shift in prenatal care that emphasizes safer, more accurate testing methods....0 Commentaires 0 Parts 365 Vue 0 Aperçu